Rituximab in moderate to severe non-renal systemic lupus erythematosus: a reanalysis of the EXPLORER study.
Marc ScherlingerClaire CarcaudMarie-Elise TruchetetThomas BarnetchePierre DuffauLionel CouziJulien SeneschalPatrick BlancoEstibaliz LazaroChristophe RichezPublished in: Annals of the rheumatic diseases (2019)